A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates

Clinical trial NCT00936897 · COMPLETED

Trial details

NCT number: NCT00936897
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2009-07-01
Primary completion: 2011-11-01
Enrollment: 833

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.